세계의 박막 의약품 제조 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Thin Film Drug Manufacturing Market is presumed to reach the market size of nearly USD 16.84 Billion by 2032 from USD 7.01 Billion in 2023 with a CAGR of 10.23% under the study period 2024-2032.

Thin film drug manufacturing involves the production of pharmaceutical dosage forms in thin films or coatings using specialized manufacturing processes and equipment. These thin film drug delivery systems typically consist of drug-containing polymer matrices or coatings that dissolve or disintegrate rapidly in the mouth or on the skin, allowing for quick absorption and onset of therapeutic effects. These technologies include solvent casting, hot melt extrusion, spray coating, and printing, which enable precise control over film thickness, drug content, and release kinetics. It offers advantages such as improved patient compliance, enhanced bioavailability, and ease of administration, making them suitable for various routes of drug delivery, including oral, buccal, sublingual, and transdermal administration.

MARKET DYNAMICS

Increasing demand for innovative drug delivery systems that offer improved patient compliance, efficacy, and convenience is fuelling the adoption of thin film technology. Thin film drug manufacturing allows for the precise deposition of pharmaceutical compounds onto a thin, flexible film substrate, which can then be administered orally, sublingually, or transdermally for rapid and controlled drug release. This technology enables the development of novel dosage forms, such as oral dissolvable films, transdermal patches, and mucoadhesive films, which offer advantages such as enhanced bioavailability, reduced dosing frequency, and improved taste masking compared to traditional oral dosage forms. Additionally, the versatility and scalability of thin film manufacturing processes, such as solvent casting, hot-melt extrusion, and inkjet printing, enable efficient production of customized drug formulations and combination products tailored to specific patient needs and therapeutic requirements. Moreover, the spurring prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and neurodegenerative conditions, is driving the demand for targeted and personalized drug delivery solutions that optimize treatment outcomes and minimize side effects. Furthermore, advancements in formulation science, materials engineering, and pharmaceutical coatings are expanding the capabilities and applications of thin film drug manufacturing in various therapeutic areas, including pain management, hormone replacement therapy, and smoking cessation. Additionally, the increasing investment in research and development by academic institutions, pharmaceutical companies, and government agencies drives innovation and technological advancements in thin film drug delivery systems. Furthermore, the emergence of regulatory pathways and guidelines supporting the development and commercialization of thin film products, along with favorable reimbursement policies for innovative drug formulations, are creating a conducive environment for market growth. However, developments in alternative drug delivery technologies and personalized medicine approaches may challenge the thin film drug manufacturing market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Thin Film Drug Manufacturing. The growth and trends of Thin Film Drug Manufacturing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Thin Film Drug Manufacturing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Oral Thin Film (Sublingual Film, Fully Dissolving Dental/Buccal Film)
• Transdermal Thin Film
• Others (Ocular Thin Film, etc.)

By Disease Indication

• Schizophrenia
• Migraine
• Opioid Dependence
• Nausea & Vomiting
• Others

By Distribution Channel

• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• E-commerce

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Thin Film Drug Manufacturing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Thin Film Drug Manufacturing market include Pfizer Inc., Novartis AG, Wolters Kluwer, Solvay, AbbVie, Sumitomo Pharma Co. Ltd, IntelGenx Corp., NAL Pharma, ZIM Laboratories Limited, Indivior PLC, MonoSol. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. THIN FILM DRUG MANUFACTURING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Disease Indication
  • 3.7.3 Market Attractiveness Analysis By Distribution Channel
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL THIN FILM DRUG MANUFACTURING MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Product
• 5.4. Oral Thin Film (Sublingual Film, Fully Dissolving Dental/Buccal Film) Historic and Forecast Sales By Regions
• 5.5. Transdermal Thin Film Historic and Forecast Sales By Regions
• 5.6. Others (Ocular Thin Film, etc.) Historic and Forecast Sales By Regions

6. GLOBAL THIN FILM DRUG MANUFACTURING MARKET ANALYSIS BY DISEASE INDICATION

• 6.1. Overview By Disease Indication
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Disease Indication
• 6.4. Schizophrenia Historic and Forecast Sales By Regions
• 6.5. Migraine Historic and Forecast Sales By Regions
• 6.6. Opioid Dependence Historic and Forecast Sales By Regions
• 6.7. Nausea & Vomiting Historic and Forecast Sales By Regions
• 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL THIN FILM DRUG MANUFACTURING MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 7.1. Overview By Distribution Channel
• 7.2. Historical and Forecast Data
• 7.3. Analysis By Distribution Channel
• 7.4. Hospital Pharmacies Historic and Forecast Sales By Regions
• 7.5. Drug Stores Historic and Forecast Sales By Regions
• 7.6. Retail Pharmacies Historic and Forecast Sales By Regions
• 7.7. E-commerce Historic and Forecast Sales By Regions

8. GLOBAL THIN FILM DRUG MANUFACTURING MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE THIN FILM DRUG MANUFACTURING COMPANIES

• 9.1. Thin Film Drug Manufacturing Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF THIN FILM DRUG MANUFACTURING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Pfizer Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Novartis AG
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Wolters Kluwer
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Solvay
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. AbbVie
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Sumitomo Pharma Co. Ltd
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. IntelGenx Corp.
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. NAL Pharma
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. ZIM Laboratories Limited
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Indivior PLC
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. MonoSol
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies